In conclusion, our findings showed the potential use of targeting the autophagy protein Beclin1 as an effective adjunctive therapy in combination with antiretrovirals for the attenuation of HIV infection and HIV-induced inflammatory molecules in the brain. The gene discussed is BECN1; the disease is HIV infectious disease.